These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2538521)

  • 1. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children.
    Gothefors L; Wadell G; Juto P; Taniguchi K; Kapikian AZ; Glass RI
    J Infect Dis; 1989 Apr; 159(4):753-7. PubMed ID: 2538521
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.
    Bernstein DI; Smith VE; Sander DS; Pax KA; Schiff GM; Ward RL
    J Infect Dis; 1990 Nov; 162(5):1055-62. PubMed ID: 2172394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
    Ho MS; Floyd RL; Glass RI; Pallansch MA; Jones B; Hamby B; Woods P; Penaranda ME; Kapikian AZ; Bohan G
    Pediatr Infect Dis J; 1989 Oct; 8(10):692-6. PubMed ID: 2554244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children.
    Rennels MB; Losonsky GA; Levine MM; Kapikian AZ
    Pediatr Infect Dis; 1986; 5(5):587-8. PubMed ID: 3020521
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines.
    Rennels MB
    J Infect Dis; 1996 Sep; 174 Suppl 1():S107-11. PubMed ID: 8752299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG.
    Isolauri E; Joensuu J; Suomalainen H; Luomala M; Vesikari T
    Vaccine; 1995 Feb; 13(3):310-2. PubMed ID: 7631519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of reactogenicity and antigenicity of M37 rotavirus vaccine and rhesus-rotavirus-based quadrivalent vaccine.
    Flores J; Perez-Schael I; Blanco M; White L; Garcia D; Vilar M; Cunto W; Gonzalez R; Urbina C; Boher J
    Lancet; 1990 Aug; 336(8711):330-4. PubMed ID: 1975333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
    Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
    J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to rotavirus vaccines among breast-fed and nonbreast-fed children.
    Glass RI; Ing DJ; Stoll BJ; Ing RT
    Adv Exp Med Biol; 1991; 310():249-54. PubMed ID: 1667065
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody responses and protection stimulated by sequential oral-parenteral immunization of mice with rotavirus.
    McNeal MM; Rae MN; Ward RL
    Vaccine; 1999 Feb; 17(7-8):639-45. PubMed ID: 10067668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of tetravalent rhesus rotavirus vaccine administered with buffer and oral polio vaccine.
    Ing DJ; Glass RI; Woods PA; Simonetti M; Pallansch MA; Wilcox WD; Davidson BL; Sievert AJ
    Am J Dis Child; 1991 Aug; 145(8):892-7. PubMed ID: 1650128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single oral dose of inactivated rotavirus and ISCOM matrices induces partial protection in lambs.
    Van Pinxteren LA; Campbell I; Clarke CJ; Snodgrass DR; Bruce MG
    Biochem Soc Trans; 1997 May; 25(2):340S. PubMed ID: 9191385
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
    Rennels MB; Wasserman SS; Glass RI; Keane VA
    Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on the development and deployment of rotavirus vaccines.
    Edelman R
    Pediatr Infect Dis J; 1987 Aug; 6(8):704-10. PubMed ID: 2823210
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
    Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
    JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children.
    Perez-Schael I; Gonzalez M; Daoud N; Perez M; Soto I; Garcia D; Daoud G; Kapikian AZ; Flores J
    J Infect Dis; 1987 Feb; 155(2):334-8. PubMed ID: 3027196
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccines against viral diarrhoea.
    Flores J; Kapikian AZ
    Baillieres Clin Gastroenterol; 1990 Sep; 4(3):675-93. PubMed ID: 1962729
    [No Abstract]   [Full Text] [Related]  

  • 18. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination.
    Kapikian AZ; Flores J; Hoshino Y; Glass RI; Midthun K; Gorziglia M; Chanock RM
    J Infect Dis; 1986 May; 153(5):815-22. PubMed ID: 3009632
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials of rotavirus vaccines.
    Vesikari T; Isolauri E; Ruuska T; Rautanen T
    Ciba Found Symp; 1987; 128():218-37. PubMed ID: 3036442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rotavirus vaccines].
    Bektimirov TA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):94-8. PubMed ID: 1965938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.